Seattle: The initiatives to combat tropical diseases that ails many millions of people in parts of Africa, Asia and Latin America, was given a renewed thrust by The Bill & Melinda Gates Foundation, which announced four grants totaling to more than $68.2 million.
This fund will assist in controlling three diseases - hookworm, leishmaniasis and trypanosomiasis - which are spread by parasites and worms. These worms are lethal in that they could impair child growth and development for life.
Advertisement
Presently no vaccines are available to prevent these diseases and the drugs that are available for treatments are too costly and prone to side effects. "Many of the world's most debilitating illnesses are virtually unheard of in the rich world. But they're a fact of life for millions of people in poor countries," said Tachi Yamada, president of the global health program at the Gates Foundation.
The funds will do a world of good to bring reprieve to the ailing millions in the grips of debilitating illnesses.
Source: Medindia
SAV
Source: Medindia
SAV
Advertisement
Advertisement
|
Advertisement
Latest Corporate News
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.